Adamant Biomedical Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	$4.33M	Buy	+130,292	New	+$4.33M	1.03%	35